Location
Overview:
Psoriasis is a genetic inflammatory diseases which affects skin. Psoriasis is charecterised by skin cells that multiply up to 10 times faster than normal. When these cells reach surface and die, raised, red plaques covered with white scales for. Psoriasis begins as a small scaling papule. When multiple papules coalesce, they form scaling plaques. These plaques tend to occur in the scalp, elbows, and knees.
Symptoms includes red patches on skin, small scaling spots, dry and cracked skin, burning, itching and soreness of skin, bleeding etc. Psoriasis is diagnosed by physical examination and skin biopsy. Psoriasis is treated by topical corticosteroids, Vitamin D analogues,Topical retinoids, Calcineurin inhibitors etc. and it can be treated by phototherapy
Segmentation:
By Trial Phase, Psoriasis pipeline drugs are segmented as:
By Company, Psoriasis pipeline drugs are segmented as:
By Drugs, Psoriasis pipeline drugs are segmented as:
By Type of Condition, Psoriasis pipeline drugs are segmented as:
By Route of Administration, Psoriasis pipeline drugs are segmented as:
Â
Space Analysis:
Report Description:
Psoriasis Disease Pipeline Drugs Assessment report studies the various therapeutics under clinical development for Psoriasis treatment along with targets for various drug candidate. The report provides plethora of information pertaining to trail phases, companies involved in the Psoriasis disease pipeline drugs development. This report studies the dynamics of the Psoriasis Disease Pipeline Drugs i.e. drivers, challenges and opportunities which are significantly impacting the product development. The report provides various information pertaining the clinical trials such as designation, grants, patents, and technology among others. Moreover, the report on Psoriasis disease pipeline drugs assessment comprehensively presents the geographic location, trial status information along with key players involved in the therapeutics development.
Key Features of the Report:
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
[urltag url='request-table-of-content']